125 related articles for article (PubMed ID: 3125374)
1. Effects of L-erythro-3, 4-dihydroxyphenylserine on sleep-wakefulness patterns and concentrations of brain catecholamines and serotonin in rats.
Mori M; Hashimoto H; Fukui K; Mori T; Noto T; Nakajima T
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):301-10. PubMed ID: 3125374
[TBL] [Abstract][Full Text] [Related]
2. Effect of DL-erythro-dihydroxyphenylserine on the locomotor activity of the mouse.
Mori T; Nakajima T; Hashimoto H; Noto T; Kato N
Pharmacol Biochem Behav; 1985 Jun; 22(6):979-83. PubMed ID: 2862644
[TBL] [Abstract][Full Text] [Related]
3. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
[TBL] [Abstract][Full Text] [Related]
4. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa.
Kato T; Karai N; Katsuyama M; Nakamura M; Katsube J
Biochem Pharmacol; 1987 Sep; 36(18):3051-7. PubMed ID: 3115271
[TBL] [Abstract][Full Text] [Related]
5. The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.
Altier H; Moldes M; Monti JM
Br J Pharmacol; 1975 May; 54(1):101-6. PubMed ID: 166716
[TBL] [Abstract][Full Text] [Related]
6. DL-threo-DOPS as a precursor of noradrenaline.
Reches A; Jackson-Lewis V; Fahn S
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-threo- and erythro-3,4-dihydroxyphenylserine on learning performance and concentrations of brain noradrenaline and its metabolites in rats.
Harada H; Noto T; Tsuji M; Taga C; Hashimoto H; Nakajima T
Pharmacol Biochem Behav; 1992 Sep; 43(1):215-21. PubMed ID: 1409807
[TBL] [Abstract][Full Text] [Related]
8. The effect of L-erythro-dihydroxyphenylserine injected into the lateral ventricle and the hypothalamus on the locomotor activity.
Noto T; Hashimoto H; Nakao J; Kamimura H; Mori T; Nakajima T
Pharmacol Biochem Behav; 1986 Aug; 25(2):411-4. PubMed ID: 3094040
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992
[TBL] [Abstract][Full Text] [Related]
12. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
[TBL] [Abstract][Full Text] [Related]
13. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
Nishino N; Fujii Y; Kondo M; Shuntoh H; Fujiwara H; Tanaka C
J Pharmacol Exp Ther; 1987 Aug; 242(2):621-8. PubMed ID: 3112367
[TBL] [Abstract][Full Text] [Related]
14. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
Sato E; Irie T; Katsube J
Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
[TBL] [Abstract][Full Text] [Related]
16. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
[TBL] [Abstract][Full Text] [Related]
17. Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
Katsube J; Kato T; Katsuyama M; Maeda Y; Nishikawa S; Nakamura M
J Pharm Pharmacol; 1986 Jul; 38(7):533-4. PubMed ID: 2875157
[TBL] [Abstract][Full Text] [Related]
18. [Formation of norapinephrine in the rat brain after administration of ((+)-erythro-3,4-dihydroxyphenylserine(author's transl)].
Constantinidis J; Geissbuhler F; Gaillard JM; Aubert C; Hovaguimian TH; Tissot R
Psychopharmacologia; 1975; 41(3):201-9. PubMed ID: 1153609
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in the caudate nucleus.
Hirose A; Sasa M; Ohno Y; Takaori S
Jpn J Pharmacol; 1988 Dec; 48(4):435-40. PubMed ID: 2907593
[TBL] [Abstract][Full Text] [Related]
20. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
